Genpharmasec Limited Reports Strong Q1 Results with 128% Revenue Growth
Genpharmasec Limited announced robust Q1 FY24 results. Consolidated revenue grew 132% to Rs 1,204.32 lakh, while profit surged 324% to Rs 121.52 lakh. Standalone revenue increased 128% to Rs 1,211.32 lakh, with profit up 165% to Rs 155.92 lakh. The pharmaceutical segment remained the primary revenue driver, contributing Rs 1,167.09 lakh. The company's Board approved these results on August 7, and confirmed no deviation in the use of proceeds from its rights issue.
25Jul 25
Genpharmasec Completes 70% Acquisition of Derren Healthcare for INR 34.15 Crores
Genpharmasec Limited has acquired a 70% stake in Derren Healthcare Private Limited for INR 34.15 crores. The acquisition, completed on July 25, 2025, marks Genpharmasec's entry into pharmaceutical formulations manufacturing. Derren Healthcare, a research-oriented company specializing in pharmaceutical products, has shown significant growth with its turnover increasing from INR 70.24 lacs in 2022-23 to INR 858.82 lacs in 2024-25. This strategic move is expected to enhance Genpharmasec's capabilities in the pharmaceutical sector.